Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results

Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; p. iv131
Main Authors: Pfeiffer, P., Glimelius, B., Winther, S., Qvortrup, C., Yilmaz, M., Berglund, À, Vistisen, K., Kersten, C., Liposits, G., Sorbye, H.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-07-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz154.014